Digital Turf War: Sun And Cipla Clash Over Online Tags
Executive Summary
Leading Indian firms spar over trademarks and domain names with the growing role of telehealth adding a new dimension to such legal disputes.
You may also be interested in...
Six Glocal Trends That Could Lift Or Drift India Pharma In 2021
Scrip takes a look at the key trends that could play out in 2021 to shape the trajectory of Indian drug makers, including evolving dynamics in the US under a new president. Thorny India-China relations will add a layer of complexity, while firms may also want to look beyond the chief information officers as they ramp up digital engagement.
OPPI Head On Sustaining Supplies In India During The Pandemic
OPPI director general and ex-MSD India chief outlines how pharma in India is ensuring medicines reach patients amid COVID-19, working closely with various stakeholders. De-risking the supply chain and up-skilling sales forces in view of widespread digital engagement are among the key issues firms are addressing.
ChatGPT Unleashed: Generative AI Use Cases Taking Off In Pharma
As generative AI and its star avatar, ChatGPT, take the world by storm, pharma is seeing traction for use cases around smarter pharmacovigilance and commercial marketing content development, among others. Senior executives from Indegene discuss this and more in an interview with Scrip.